Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Suhrbier

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Nature Medicine|October 15, 1998
Vaccine-induced cytotoxic T lymphocytes protect against retroviral challengeA D Hislop, M F Good, L Mateo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
An HLA-A2 polyepitope vaccine for melanoma immunotherapyL Mateo, J Gardner, Q Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1993
EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2R Khanna, S R Burrows, A Suhrbier, et al.
The British Journal of Dermatology|March 8, 2011
The sap from Euphorbia peplus is effective against human nonmelanoma skin cancersJ R Ramsay, A Suhrbier, J H Aylward, et al.
Journal of Virology|June 11, 1999
Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopesT Woodberry, J Gardner, L Mateo, et al.
Gene Therapy|December 19, 2008
A Kunjin replicon vector encoding granulocyte macrophage colony-stimulating factor for intra-tumoral gene therapyD Hoang-Le, L Smeenk, I Anraku, et al.
The Journal of Experimental Medicine|December 1, 1994
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virusV P Argaet, C W Schmidt, S R Burrows, et al.
Blood|December 12, 2001
Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral loadS L Silins, M A Sherritt, J M Silleri, et al.
European Journal of Immunology|October 30, 1999
H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategiesH Firat, F Garcia-Pons, S Tourdot, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1996
Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopesS A Thomson, S L Elliott, M A Sherritt, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Nature Medicine|October 15, 1998
Vaccine-induced cytotoxic T lymphocytes protect against retroviral challengeA D Hislop, M F Good, L Mateo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
An HLA-A2 polyepitope vaccine for melanoma immunotherapyL Mateo, J Gardner, Q Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1993
EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2R Khanna, S R Burrows, A Suhrbier, et al.
The British Journal of Dermatology|March 8, 2011
The sap from Euphorbia peplus is effective against human nonmelanoma skin cancersJ R Ramsay, A Suhrbier, J H Aylward, et al.
Journal of Virology|June 11, 1999
Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopesT Woodberry, J Gardner, L Mateo, et al.
Gene Therapy|December 19, 2008
A Kunjin replicon vector encoding granulocyte macrophage colony-stimulating factor for intra-tumoral gene therapyD Hoang-Le, L Smeenk, I Anraku, et al.
The Journal of Experimental Medicine|December 1, 1994
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virusV P Argaet, C W Schmidt, S R Burrows, et al.
Blood|December 12, 2001
Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral loadS L Silins, M A Sherritt, J M Silleri, et al.
European Journal of Immunology|October 30, 1999
H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategiesH Firat, F Garcia-Pons, S Tourdot, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1996
Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopesS A Thomson, S L Elliott, M A Sherritt, et al.
Pageof 7